The specific inhibitor SK1-I, either alone or in combination with chemotherapy, inhibited SPHK1 expression or SPHK1 activity, making NSCLC cells significantly more sensitive to apoptosis induced by chemotherapy drugs in vitro and in vivo. The gene discussed is SPHK1; the disease is non-small cell lung carcinoma.